Home
>
National Drug Code (NDC)
>
lisinopril
lisinopril - 52125-165-02 - (lisinopril)
Drug Information of lisinopril
| Product NDC: | 52125-165 |
| Proprietary Name: | lisinopril |
| Non Proprietary Name: | lisinopril |
| Active Ingredient(s): | 20 mg/1 & nbsp; lisinopril |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of lisinopril
| Product NDC: | 52125-165 |
| Labeler Name: | REMEDYREPACK INC. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075994 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130320 |
Package Information of lisinopril
| Package NDC: | 52125-165-02 |
| Package Description: | 30 TABLET in 1 BLISTER PACK (52125-165-02) |
NDC Information of lisinopril
| NDC Code | 52125-165-02 |
| Proprietary Name | lisinopril |
| Package Description | 30 TABLET in 1 BLISTER PACK (52125-165-02) |
| Product NDC | 52125-165 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | lisinopril |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20130320 |
| Marketing Category Name | ANDA |
| Labeler Name | REMEDYREPACK INC. |
| Substance Name | LISINOPRIL |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
